What You'll Do:
- Learn about Synthego's RNA synthesis, purification, and analysis processes
- Learn how to operate and develop new analytical methods, including high-performance liquid chromatography, mass spectrometry, and next-generation sequencing
- Learn the manufacturing workflow of synthetic RNA
- Use experimental design principles
- Perform data analysis and present findings
- Shadowing, mentoring, and training opportunities with industry professionals
- Opportunity to participate in networking events and company meetings
About You:
- Pursuing a degree in Biology, Chemistry, Bioengineering, Molecular Biology, or other similar degrees
- Interest in learning about synthetic RNA/DNA
- Interest in learning about process & assay development
- Strong written and verbal communication skills
- Able to multi-task and prioritize work effectively
- Ability to work for 10 weeks within a period in June to August
Bonus Qualifications:
- Experience with working in labs
- Experience with Python
- Good presentation skills
- Experience with pipetting
Benefits & Perks:
- School credit if applicable
- Letter of reference
- Competitive pay
- Free catered lunches on Tuesdays and Thursdays
Top Skills
What We Do
Synthego is a genome engineering company enabling the acceleration of life science research and development in the pursuit of improved human health.
The company leverages machine learning, automation, and gene editing to build platforms for science at scale. By vertically integrating hardware, software, bioinformatics, chemistry, and molecular biology, Synthego is at the forefront of innovation advancing the next generation of medicines through providing access to genome editing at an unprecedented scale.
////
Our Culture of Diversity: Different Faces from Different Places
At Synthego, our differences make us unique, help us innovate, and allow us to persevere. We stand firmly behind our values, strive to achieve representation, and celebrate diversity in perspectives and backgrounds. We welcome all team members to be their best selves as we move forward towards fulfilling our shared vision of revolutionizing genome engineering technology to help make biological therapies accessible to all patients.
